Orbimed Advisors LLC Sells in Q2 2025

Orbimed Advisors LLC

  • $2.8 Billion
  • Q2 2025
Stock Shares change Price Range Shares Held Trade History
NBIX
Neurocrine Biosciences Inc

Healthcare
-496K
- 53.08%
$87.54 - $128.18 $43.4M - $63.6M
439K $55.1M
TMO
Thermo Fisher Scientific Inc.

Healthcare
-82.5K
- 63.95%
$390.26 - $489.06 $32.2M - $40.3M
46.5K $18.9M
TARS
Tarsus Pharmaceuticals, Inc.

Healthcare
-456K
- 69.73%
$39.88 - $51.49 $18.2M - $23.5M
198K $8.02M
CYTK
Cytokinetics Inc

Healthcare
-432K
- 28.64%
$29.84 - $42.92 $12.9M - $18.6M
1.08M $35.6M
ITGR
Integer Holdings Corp

Healthcare
-229K
- 34.58%
$106.73 - $126.93 $24.5M - $29.1M
433K $53.3M
NPCE
Neuro Pace Inc

Healthcare
-792K
- 23.26%
$10.34 - $18.13 $8.19M - $14.4M
2.61M $29.1M
IMTX
Immatics N.V.

Healthcare
-2.37M
- 76.68%
$3.5 - $6.14 $8.29M - $14.5M
720K $3.87M
TYRA
Tyra Biosciences, Inc.

Healthcare
-948K
- 54.1%
$7.06 - $10.86 $6.69M - $10.3M
805K $7.7M
RYTM
Rhythm Pharmaceuticals, Inc.

Healthcare
-131K
- 34.6%
$46.95 - $68.11 $6.17M - $8.96M
249K $15.7M
KRYS
Krystal Biotech, Inc.

Healthcare
-14.3K
- 60.85%
$123.36 - $181.0 $1.76M - $2.59M
9.2K $1.26M
INSM
Insmed Inc

Healthcare
-15.2K
- 53.04%
$64.81 - $105.9 $985K - $1.61M
13.5K $1.35M
CMMB
Chemomab Therapeutics Ltd.

Healthcare
-800K
- 45.96%
$0.94 - $1.42 $752K - $1.14M
941K $1.09M
PASG
Passage Bio, Inc.

Healthcare
-979K
- 13.92%
$0.27 - $0.48 $264K - $470K
6.06M $2.42M
Engene Holdings Inc
-214K
- 23.96%
N/A
678K $0
Lakeshore Biopharma CO LTD
-85.6K
- 60.98%
N/A
54.8K $0
Cg Oncology Inc
-594K
- 24.04%
N/A
1.88M $0
SIBN
Si Bone, Inc.

Healthcare
-864K
- 25.09%
$13.05 - $19.71 $11.3M - $17M
2.58M $48.5M
AMLX
Amylyx Pharmaceuticals, Inc.

Healthcare
-34.8K
- 10.0%
$3.31 - $6.5 $115K - $226K
313K $2.01M
ABCL
Ab Cellera Biologics Inc.

Healthcare
-836K
- 20.0%
$1.93 - $3.8 $1.61M - $3.18M
3.34M $11.5M
EXAS
Exact Sciences Corp

Healthcare
-72.5K
- 10.66%
$40.31 - $58.08 $2.92M - $4.21M
607K $32.3M
ADCT
Adc Therapeutics Sa

Healthcare
-61.1K
- 1.02%
$1.1 - $3.67 $67.2K - $224K
5.91M $15.8M
ALNY
Alnylam Pharmaceuticals, Inc.

Healthcare
-4.2K
- 1.21%
$224.32 - $326.09 $942K - $1.37M
342K $111M
Activity Summary
Buys All Purchases 33 New Holdings 14 Increased Positions 19 Sells All Sells 23 Reductions 23 Sold out 0 Options Calls 4 Puts 1
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email